Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ACTRN12626000579392) titled 'Cystoscopic Local Endoscopic Application of RADA16 (PuraStat(R)) for refractory haematuria secondary to Radiation Cystitis) (CLEAR-RC)' on May 8.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Sydney Unversity
Condition:
radiation cystitis
Haematuria
radiation cystitis
Haematuria
Surgery - Surgical techniques
Renal and Urogenital - Other renal and urogenital disorders
Intervention:
- A urologist will apply RADA16 (Purastat- 3 or 5 ml depending on the ...